RxDoctor Payments Data

Jessica Wang

Nurse Practitioner · San Gabriel, CANPI 1003299033

Payments from drug & device makers

$1,720in general payments, 2019–2025

Across 48 payments — averaging $35.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$442
  • Novo Nordisk$166
  • GSK$142
  • E.r. Squibb & Sons, L.L.C.$125
  • Bayer$121
  • Novartis$117
  • plus $606 from 16 others

What the payments were for

  • Food & beverage$1,54490%
  • Education$17610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,720 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide19$25,638
JardianceEmpagliflozin26$23,335
OzempicSemaglutide18$21,424
JanuviaSitagliptin Phosphate15$17,672
Humulin NInsulin Nph Human Isophane25$4,591
Humulin 70-30Insulin Nph Hum/Reg Insulin Hm21$3,502
Atorvastatin Calcium138$2,647
Sucralfate71$1,717
Tamsulosin Hcl42$1,565
Rosuvastatin Calcium32$1,359
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic13$1,232
Ultra-Fine Short Pen NeedlePen Needle, Diabetic14$1,022
Amlodipine Besylate76$847
Losartan Potassium47$755
Lansoprazole50$744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Humulin N, Humulin 70-30$48$33,73265 claims
Boehringer IngelheimJardiance$60$23,33526 claims
Novo NordiskOzempic$166$21,42418 claims
MerckJanuvia$30$17,67215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in San Gabriel

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →